Avicenna Holdings Limited has been acquired by Juno Health
The shareholders of Avicenna Holdings Limited have sold the business to Juno Health.
Based in the UK, Avicenna comprises 21 pharmacies, as well as a buying group operation serving more than 1,000 independent pharmacies.
Juno Health is a UK-based company that operates a chain of pharmacy stores. The community pharmacies will be integrated into Juno’s existing chain with the buying group continuing to be run by Salim Jetha, Avicenna CEO. It will become the industry-leading buying and support group for independent pharmacies across the UK. Juno has considerable experience in the sector and the combination of Avicenna resources and expertise will support the independent pharmacy sector and improve membership benefits.
Richard Smith, Chairman at Juno Health, said: “Avicenna is a well-established business delivering clear benefits to its members. It is one of the most recognizable brands among independent pharmacists and extremely well respected.”
Oaklins Cavendish, based in the UK, advised the shareholders of Avicenna on the sale of the business to Juno Health.
Talk to the deal team
Related deals
Bellefleur has been acquired by Domidep
Belgian nursing home Bellefleur has been sold to Domidep, one of France’s largest private nursing home operators.
Learn moreTransDigm Group has acquired Raptor Scientific from L Squared Capital Partners for US$655 million
TransDigm Group Incorporated (NYSE: TDG) has successfully completed its acquisition of Raptor Scientific, a portfolio company of L Squared Capital Partners, for approximately US$655 million in cash.
Learn moreManagement and founders of Sansidor have successfully invested alongside IK Partners
IK Partners has signed an agreement to invest in Sansidor, a fast-growing testing, inspection and related services provider. IK is investing in the group alongside existing shareholders HC Partners, founders of Sansidor’s group companies and the current management team.
Learn more